Hannah Joseph Hospital Limited has issued a regulatory disclosure to BSE Limited regarding an upcoming Board of Directors meeting. The meeting is scheduled to be held on Thursday, November 5, 2026, at the company's Corporate Office. The primary agenda item is to consider and approve the Unaudited Financial Results along with the Limited Review Report for the half year ended September 30, 2026.
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and the company's Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the company's securities has been closed since October 1, 2026. The closure applies to Directors, Designated Persons, and their immediate relatives. The Trading Window will remain closed until 48 hours after the declaration of the aforementioned Unaudited Financial Results for the half year ended September 30, 2026.
The disclosure is made under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The document is digitally signed by Dr. Moses Joseph Arunkumar, Managing Director (DIN: 03608603).